ADORA2A and Alzheimer disease: The A2AR antagonist SCH58261 regulated both P2×7 and P2Y1R‐mediated [Ca2+]i responses in astrocytes, confirming that A2ARs controlled the P2X7 and P2Y1R‐mediated [Ca2+]i dynamics, which are disrupted in conditions of early AD.